Abstract:This article reports the synthesis, characterization, cytotoxic activity, antimicrobial activity, antioxidant activity, and theoretical calculations of four different thymol‐based derivatives. The synthesized compounds were found to have cytotoxic effects against three different cancer cell lines including lung, liver, and colon. Inhibition zone values, minimum inhibitory concentrations, and minimum bactericidal/fungicidal concentrations of compounds against Gram‐negative bacteria, Gram‐positive bacteria, and a pathogenic yeast species were determined. DPPH free radical scavenging activities of compounds were tested. The results showed that all compounds had higher antioxidant activity than thymol. Quantum chemical calculations were performed to explain the nature of the transitions in the absorption spectra. Docking simulations of compounds towards two potential molecular targets were performed to validate the anticancer and antimicrobial activities. A set of thymol‐based derivatives (3 a–d) was synthesized and characterized. Quantum chemical calculations were performed to explain the nature of the transitions in the absorption spectra. These new compounds were tested as anticancer agents on human liver (HepG2), lung (A549), and colon (DLD‐1) cancer cell lines using the 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl tetrazolium bromide method showing in some cases higher antiproliferative properties than the reference drug cisplatin. All synthesized compounds were also screened for their antimicrobial activity against a representative panel of Gram‐positive and Gram‐negative bacteria plus a pathogenic yeast species (Candida albicans ATCC90028) using agar disc diffusion and broth microdilution assays. Furthermore, we determined the antioxidant activity of these compounds by the DPPH free radical scavenging test. According to the minimum bactericidal concentration, minimum fungicidal concentration, and IC50 values, compound 3 c showed the highest antimicrobial activity, compound 3 d exhibited the highest antioxidant activity, while compounds 3 b and 3 c displayed higher cytotoxic activity than cisplatin against HepG2 and DLD‐1 cell lines albeit no selectivity towards healthy cells (HEK‐293T). Furthermore, docking simulations of the compounds towards two potential molecular targets, namely caspase‐3 protein (PDB ID: 3KJF) and Escherichia coli glucosamine‐6‐phosphate synthase (PDB ID: 2VF5), were performed in order to validate the anticancer and antimicrobial activities, respectively.

Biological Activities, DFT Calculations, and Molecular Docking Simulation of Thymol‐Based Compounds

Biological evaluations and computational studies of newly synthesized thymol-based Schiff bases as anticancer, antimicrobial and antioxidant agents

Synthesis, Molecular Docking and Antitumor Activity of New Dithiazoles

Thymol and carvacrol derivatives as anticancer agents; synthesis, in vitro activity, and computational analysis of biological targets

Determination of Antioxidant, Antimicrobial and Anticancer Properties of Newly Synthesized 2‐methoxyphenyl Thiophene Derivatives

Synthesis and molecular docking of some new thiazolidinone and thiadiazole derivatives as anticancer agents

Synthesis, crystal structure and evaluation of anticancer activities of some novel heterocyclic compounds based on thymol

Synthesis, Molecular Docking Study, and Cytotoxicity Evaluation of Some Novel 1,3,4-Thiadiazole as Well as 1,3-Thiazole Derivatives Bearing a Pyridine Moiety

Synthesis and Characterization of Oxime Derivatives and their Some Transition Metal Complexes with Thiadiazole Groups: Biological Activities, and Molecular Docking Studies of the Ligands

Synthesis and Preliminary Studies of Biological Activity

Synthesis, molecular modelling and biological significance of N-(4-(4-bromophenyl) thiazol-2-yl)-2-chloroacetamide derivatives as prospective antimicrobial and antiproliferative agents

Synthesis and Cytotoxicity Evaluation of 2-(4-((1,3-Dioxoisoindolin-2-yl)methyl)phenyl)-N-phenyl-thiazole-4-carboxamide Derivatives as Apoptosis Inducers with Potential Anticancer Effects

Synthesis, Biological Evaluation, and Docking Study of a New Series of Thiophene Derivatives Based on 3‐Oxobutanamidothiophene as an Anticancer Agent

An efficient synthesis, characterization, and in silico studies of novel chromenes, thiophenes, pyrazolo[1,5-a]pyrimidines, and pyrimidines as potential antimicrobial and anticancer agents using the bio-buffer tris(hydroxymethyl)aminomethane (THAM)

Potential thiosemicarbazone-based enzyme inhibitors: Assessment of antiproliferative activity, metabolic enzyme inhibition properties, and molecular docking calculations

Synthesis, Antitumor and Antimicrobial Evaluation of Novel 1,3,4-Thiadiazole Derivatives Bearing Disulfide Bond

Synthesis and Cytotoxicity of Methyl-4,8-dihydrobenzo[1,2-b:5,4-b′]dithiophene-4,8-dione Derivatives

Synthesis, Antimicrobial, and Antioxidant Evaluation of Some New Thiazole‐Schiff Base Derivatives

Cytotoxic Evaluation, Molecular Docking, and 2D-QSAR Studies of Dihydropyrimidinone Derivatives As Potential Anticancer Agents.

Exploring the effect of substituents on the supramolecular assemblies built by non-covalent interactions in three closely related 1,3,4-oxadiazole-2(3 H )-thione derivatives: An evaluation of antimicrobial and anti-proliferative activities

Anti-proliferative, Morphological and Molecular Docking Studies of New Thiophene Derivatives and their Strategy in Ionic Liquids Immobilized Reactions